Unpacking the interplay between alcohol use and the GLP-1 system: Recent evidence from human and rodent studies

被引:0
|
作者
Farokhnia, M. [1 ,2 ]
Leggio, L. [1 ,2 ]
机构
[1] Natl Inst Hlth, Baltimore, MD 21224 USA
[2] Natl Inst Hlth, Bethesda, MD 21224 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
121
引用
收藏
页码:65 / 65
页数:1
相关论文
共 31 条
  • [1] Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
    Mehdi Farokhnia
    Christopher T. Rentsch
    Vicky Chuong
    M. Adrienne McGinn
    Sophie K. Elvig
    Eliza A. Douglass
    Luis A. Gonzalez
    Jenna E. Sanfilippo
    Renata C. N. Marchette
    Brendan J. Tunstall
    David A. Fiellin
    George F. Koob
    Amy C. Justice
    Lorenzo Leggio
    Leandro F. Vendruscolo
    Molecular Psychiatry, 2022, 27 : 4642 - 4652
  • [2] Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
    Farokhnia, Mehdi
    Rentsch, Christopher T.
    Chuong, Vicky
    McGinn, M. Adrienne
    Elvig, Sophie K.
    Douglass, Eliza A.
    Gonzalez, Luis A.
    Sanfilippo, Jenna E.
    Marchette, Renata C. N.
    Tunstall, Brendan J.
    Fiellin, David A.
    Koob, George F.
    Justice, Amy C.
    Leggio, Lorenzo
    Vendruscolo, Leandro F.
    MOLECULAR PSYCHIATRY, 2022, 27 (11) : 4642 - 4652
  • [3] CONVERGING EVIDENCE FROM RODENT AND HUMAN STUDIES ON THE ROLE OF SPIRONOLACTONE AS A POTENTIAL PHARMACOTHERAPY FOR ALCOHOL USE DISORDER
    Farokhnia, Mehdi
    Rentsch, Christopher T.
    Chuong, Vicky
    McGinn, M. Adrienne
    Elvig, Sophie K.
    Douglass, Eliza A.
    Gonzalez, Luis A.
    Sanfilippo, Jenna E.
    Marchette, Renata C. N.
    Tunstall, Brendan J.
    Fiellin, David A.
    Koob, George F.
    Justice, Amy C.
    Leggio, Lorenzo
    Vendruscolo, Leandro F.
    ALCOHOL, 2023, 109 : 83 - 84
  • [4] Antagonism of the Mineralocorticoid Receptor as a Potential Pharmacotherapy for Alcohol Use Disorder: Convergent Evidence From Rodent and Human Studies
    Farokhnia, Mehdi
    Rentsch, Christopher
    McGinn, Adrienne
    Tunstall, Brendan
    Gregory-Flores, Adriana
    Koob, George
    Fiellin, David
    Vendruscolo, Leandro
    Justice, Amy
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 152 - 152
  • [5] The Glucagon-Like Peptide-1 (GLP-1) System is Modulated by Acute and Chronic Exposure to Alcohol: Findings from Human Laboratory and Brain Postmortem Studies
    Farokhnia, Mehdi
    Lee, Mary R.
    Sun, Hui
    Suchankova, Petra
    Leggio, Lorenzo
    FASEB JOURNAL, 2019, 33
  • [6] Converging evidence from human pharmacoepidemiology and rodent psychopharmacology studies on the role of spironolactone as a potential pharmacotherapy for alcohol use disorder
    Farokhnia, Mehdi
    Rentsch, Christopher
    Chuong, Vicky
    McGinn, Adrienne
    Elvig, Sophie
    Douglass, Eliza
    Sanfilippo, Jenna
    Marchette, Renata
    Tunstall, Brendan
    Fiellin, David
    Koob, George
    Justice, Amy C.
    Leggio, Lorenzo
    Vendruscolo, Leandro
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 348 - 349
  • [7] Alcohol Consumption Interacts With the Glucagon-Like Peptide-1 (GLP-1) System: A Novel Therapeutic Target for Alcohol Use Disorder?
    Farokhnia, Mehdi
    Browning, Brittney
    Min, Sarah
    Sun, Hui
    Suchankova, Petra
    Farinelli, Lisa
    Lee, Mary
    Akhlaghi, Fatemeh
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 255 - 255
  • [8] Effects of GLP-1(9-36) and exendin-4 on glucagon secretion from human islets of Langerhans: evidence of a novel GLP-1 receptor in islets?
    Ramracheya, R. D.
    Shigeto, M.
    Johnson, P.
    Thorens, B.
    Clark, A.
    Rorsman, P.
    DIABETIC MEDICINE, 2014, 31 : 5 - 6
  • [9] The crosstalk between alcohol use and glucagon-like peptide-1 (GLP-1) in humans and rodents: an emerging pharmacotherapeutic target?
    Farokhnia, M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 73 - 74
  • [10] Alcohol intake in non-human primates and alcohol cue-induced brain activation in alcohol use disorder patients: Effects of GLP-1 receptor agonists
    Fink-Jensen, A.
    Klausen, M. K.
    Jensen, M. E.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 66 - 66